
GIOS Biostructures provides integrated, end-to-end structural biology services to speed drug discovery. It uses automated X-ray crystallography, fragment-based screening, AI-driven protein design and engineering, and gene-to-protein workflows. Core technologies include X-ray crystallography, AI, protein design and engineering, E. coli expression systems, and the GIOS MESO platform to improve solubility and stability for challenging targets. The company serves pharmaceutical and biotechnology firms and academic laboratories seeking tailored protein solutions to accelerate therapeutic discovery.

GIOS Biostructures provides integrated, end-to-end structural biology services to speed drug discovery. It uses automated X-ray crystallography, fragment-based screening, AI-driven protein design and engineering, and gene-to-protein workflows. Core technologies include X-ray crystallography, AI, protein design and engineering, E. coli expression systems, and the GIOS MESO platform to improve solubility and stability for challenging targets. The company serves pharmaceutical and biotechnology firms and academic laboratories seeking tailored protein solutions to accelerate therapeutic discovery.